Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Critical Elements Lithium Corp V.CRE

Alternate Symbol(s):  CRECF

Critical Elements Lithium Corporation is a Canada-based lithium exploration company. The Company is engaged in the acquisition, exploration, development and processing of critical minerals mining properties in Canada. Its projects include Rose Lithium-Tantalum, Rose North, Rose South, Arques, Bourier, Dumulon, Duval, Nisk, Lemare, Caumont, and Valiquette. The Rose Lithium-Tantalum property consists of over 473 claims covering a total area of over 24.99 square kilometers (km2). It lies in the northeastern part of Superior Province, within the Eastmain greenstone belt. The Rose North property consists of about 31 claims covering a total area of over 16.14 km2. The Arques Property is composed of one block totaling around 136 claims covering an area of 6,840.93 hectares (ha) over 18 kilometers (kms) in length in a Southwest-Northeast direction. Bourier Property is comprised of over 304 claims with an area of 15,616.47 ha for over 30 kms. Rose South property consists of over 280 claims.


TSXV:CRE - Post by User

Comment by HuntNGatheron Nov 05, 2021 4:38pm
255 Views
Post# 34094197

RE:RE:RE:RE:understanding the deal, more questions than answers for me

RE:RE:RE:RE:understanding the deal, more questions than answers for meI take some comfort knowing that Cantor Fitzgerald is a Bay Street big deal.  They are a Wall Street big deal.  They are going to bring some US eyes to the company and while it totally sucks that we have to see a financing that kneecaps the share price, I like the One-Half warrant a significant premium to where we were even yesterday.
That signals to me that they believe there will be considerable upside (more than double) for that math to make any sense.

If they have their big wallet investros at CF who will take this full amount quickly it is not because they are granny and gramps buy and hold investors for the long term.

They are likely players who want a piece of something that is on the way up and quick.
JMO.

BUT, I do know that they don't bother looking at things like this for 2x multiples.  They are thinking bigger than that and they can then start to drive the bus a little more by getting exposure and action stateside.

I have been crushed in biotechs before with financings that totally sh!t the bed.
BUT, I have also had the good fortune of what would seem to be a terrible financing with a great set of investors who ended up making the little biotech move to a takeout target for a major pharma at about 40x.

Not getting greedy here... but I would think that 3-5 x is not unreasonable.

Raise money when you CAN....not when you HAVE TO.
I hate hearing it.  But it is often very true.
In Biotech it is often in the weeks leading up to a data release when everything is frothy.  It hurts but thankfully it means the company can live to fight another day if the results are less than stunning.

JMO.  
GLTAL
HnG
<< Previous
Bullboard Posts
Next >>